TCL Archive Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer August 27, 2010
TCL Archive NTP Committee Finds Five Test Reports Show “Limited” Evidence Of Carcinogenicity February 27, 1981
TCL Archive Bristol-Myers Runs Afoul Of FDA In Attempt To Distribute Chapters of Oncology Textbook June 19, 1992